As of 2025-08-04, the EV/EBITDA ratio of Cogent Biosciences Inc (COGT) is -33.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. COGT's latest enterprise value is 1,977.19 mil USD. COGT's TTM EBITDA according to its financial statements is -59.04 mil USD. Dividing these 2 quantities gives us the above COGT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-07-29 | -34.78 |
| 2025-07-28 | -35.52 |
| 2025-07-25 | -35.46 |
| 2025-07-24 | -35.81 |
| 2025-07-23 | -36.34 |
| 2025-07-22 | -36.57 |
| 2025-07-21 | -36.13 |
| 2025-07-18 | -36.69 |
| 2025-07-17 | -35.84 |
| 2025-07-16 | -34.84 |
| 2025-07-15 | -33.78 |
| 2025-07-14 | -32.58 |
| 2025-07-11 | -32.26 |
| 2025-07-10 | -31.87 |
| 2025-07-09 | -30.55 |
| 2025-07-08 | -28.73 |
| 2025-07-07 | -27.47 |
| 2025-07-03 | -22.27 |
| 2025-07-02 | -21.77 |
| 2025-07-01 | -21.21 |
| 2025-06-30 | -21.09 |
| 2025-06-27 | -20.86 |
| 2025-06-26 | -21.53 |
| 2025-06-25 | -20.77 |
| 2025-06-24 | -21.27 |
| 2025-06-23 | -21.33 |
| 2025-06-20 | -21.24 |
| 2025-06-18 | -21.27 |
| 2025-06-17 | -22.39 |
| 2025-06-16 | -22.00 |
| 2025-06-13 | -20.80 |
| 2025-06-12 | -21.21 |
| 2025-06-11 | -21.33 |
| 2025-06-10 | -21.80 |
| 2025-06-09 | -20.27 |
| 2025-06-06 | -19.98 |
| 2025-06-05 | -17.60 |
| 2025-06-04 | -16.57 |
| 2025-06-03 | -17.01 |
| 2025-06-02 | -16.48 |
| 2025-05-30 | -15.98 |
| 2025-05-29 | -16.19 |
| 2025-05-28 | -14.34 |
| 2025-05-27 | -14.34 |
| 2025-05-23 | -14.16 |
| 2025-05-22 | -14.54 |
| 2025-05-21 | -14.63 |
| 2025-05-20 | -15.60 |
| 2025-05-19 | -14.63 |
| 2025-05-16 | -14.34 |